Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents

被引：0
|
作者：
Jumpei Teramachi
Hirokazu Miki
Shingen Nakamura
Masahiro Hiasa
Takeshi Harada
Masahiro Abe
机构：
[1] Tokushima University Graduate School of Biomedical Sciences,Department of Hematology, Endocrinology and Metabolism
[2] Okayama University Graduate School,Department of Oral Function and Anatomy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences
[3] Tokushima University Hospital,Division of Transfusion Medicine and Cell Therapy
[4] Tokushima University Graduate School of Biomedical Sciences,Department of Community Medicine and Medical Science
[5] Tokushima University Graduate School of Biomedical Sciences,Department of Orthodontics and Dentofacial Orthopedics
来源：
Journal of Bone and Mineral Metabolism | 2023年 / 41卷
关键词：
Myeloma bone disease; Receptor activator of nuclear factor-κB ligand; Bone-modifying agents; Proteasome inhibitors; Daratumumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：388 / 403
页数：15
相关论文
共 50 条
  • [21] Thiazolidinediones: A novel class of agents with anti-myeloma activity.
    Mitsiades, CS
    Mitsiades, N
    Poulaki, V
    Treon, SP
    Anderson, KC
    BLOOD, 2001, 98 (11) : 376A - 376A
  • [22] Anti-myeloma Effect of Xanthohumol on Multiple Myeloma Cells
    Tucker, Michael
    Rayalam, Srujana
    Wang, Xinyu
    FASEB JOURNAL, 2020, 34
  • [23] HUMAN HERPESVIRUS 6 IS A FREQUENT INFECTION IN MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE ERA OF NOVEL ANTI-MYELOMA AGENTS
    Horowitz, N.
    Lavi, N.
    Zuckerman, T.
    Benyamini, N.
    Oren, I.
    Kra-Oz, Z.
    Held, V.
    Avivi, I.
    HAEMATOLOGICA, 2012, 97 : 397 - 397
  • [24] Synergistic inhibition of myeloma cell growth by combinations of dexamethasone with other anti-myeloma agents.
    Bakker, F
    Ott, A
    Richter, K
    Ahrens, T
    Guenther, A
    Burger, R
    Gramatzki, M
    BLOOD, 2005, 106 (11) : 358B - 358B
  • [25] ANTI-MYELOMA EFFECT OF CANNABINOIDS
    Barbado, V.
    Medrano, M.
    Caballero-Velazquez, T.
    Alvarez-Laderas, I.
    Sanchez-Abarca, L. I.
    Garcia-Guerreo, E.
    Martin-Sanchez, J.
    Rosado, I. V.
    Gonzalez-Naranjo, P.
    Campillo, N.
    Piruat, J. I.
    Paez, J. A.
    Perez-Simon, J. A.
    HAEMATOLOGICA, 2016, 101 : 515 - 516
  • [26] Mechanical Loading Shows Anti-Myeloma Effects While Rescuing Bone Loss with Net Bone Formation in a Myeloma Bone Disease Murine Model
    Ziouti, Fani
    Rummler, Maximilian
    Brandl, Andreas
    Beilhack, Andreas
    Lynch, Maureen
    Willie, Bettina
    Jundt, Franziska
    BLOOD, 2018, 132
  • [27] Myeloma bone disease: Progress in pathogenesis
    Xi, Hao
    An, Ran
    Li, Lu
    Wang, Gang
    Tao, Yi
    Gao, Lu
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2016, 122 (02): : 149 - 155
  • [28] The pathogenesis of the bone disease of multiple myeloma
    Edwards, Claire M.
    Zhuang, Junling
    Mundy, Gregory R.
    BONE, 2008, 42 (06) : 1007 - 1013
  • [29] Invasive Pulmonary Aspergillosis in Multiple Myeloma patients: A sizeable diagnosis in the era of novel anti-myeloma therapies
    Fuchs, Eyal
    Lavi, Noa
    Carasso, Yariv
    Oren, Ilana
    Hardak, Emilia
    MYCOSES, 2021, 64 (10) : 1298 - 1303
  • [30] Multiple myeloma - in-vitro studies of new compounds with potential anti-myeloma activity
    Steiner, N.
    Kern, J.
    Untergasser, G.
    Willenbacher, W.
    Gastl, G.
    Gunsilius, E.
    ONKOLOGIE, 2013, 36 : 148 - 149
12345